European Medicines Agency’s (EMA) Fluoroquinolone Press Release 2019:
European Medicines Agency’s (EMA) Fluoroquinolone Public Hearing 2018:
13 patient testimonies before the EMA 2018 starting at minute 14:15
https://www.youtube.com/watch?v=1vao8o5NGUc
Pharmacovigilance Risk Assessment Committee (PRAC) Assessment Report 2018:
The following mechanisms may be supportive of a causal relationship between (fluoro) quinolones and tendon disorders:
Tendon disorders
Neurotoxicity
Neuropathies
Phototoxicity
Vasculitis
******************************************************************************************************
Interactive Drug Analysis Profile (ADR's):
Levofloxacin: https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000197682791.zip&agency=MHRA
Your support and contributions will help fund our latest research study currently in process.
Copyright © 2020 - All Rights Reserved.
Powered by GoDaddy Website Builder